Last update
5/8/2026
Reviewed By
Overview
SCIENTIFIC SCORE
Likely Very Effective
Based on 1 Research
9
USERS' SCORE
Good
Based on 6 Reviews
8.5
Supplement Facts
Serving Size: 1 Veg Capsule
Amount Per Serving
%DV
Iron (elemental) (from 180 mg Ferrous Bisglycinate)(Ferrochel™)
36 mg
200%
Top Medical Research Studies
9
We explored the impact of iron on chemotherapy effectiveness, particularly in the treatment of osteosarcoma (OS). The study revealed promising insights into how combining iron with eriodictyol and cisplatin could promote ferroptosis—a form of regulated cell death that can improve the overall effectiveness of cancer therapies.
The researchers discovered that eriodictyol can curb a protein known as BACH1, which leads to reduced production of GPX4, a key player in protecting cells from ferroptosis. By diminishing GPX4 levels, this combination appears to push cancer cells towards ferroptosis more effectively.
Moreover, employing hollow mesoporous nanocubes to deliver eriodictyol and cisplatin seamlessly combines these agents to enhance cell death in OS. Through multiple mechanisms, including the depletion of protective molecules and the direct initiation of fatal processes in cancer cells, the nanocomplex showed impressive results in both lab tests and animal studies.
Importantly, the treatment demonstrated effectiveness without causing significant harm to other organs, hinting at its potential as a therapeutic strategy for OS patients in need of better treatment options.
The researchers discovered that eriodictyol can curb a protein known as BACH1, which leads to reduced production of GPX4, a key player in protecting cells from ferroptosis. By diminishing GPX4 levels, this combination appears to push cancer cells towards ferroptosis more effectively.
Moreover, employing hollow mesoporous nanocubes to deliver eriodictyol and cisplatin seamlessly combines these agents to enhance cell death in OS. Through multiple mechanisms, including the depletion of protective molecules and the direct initiation of fatal processes in cancer cells, the nanocomplex showed impressive results in both lab tests and animal studies.
Importantly, the treatment demonstrated effectiveness without causing significant harm to other organs, hinting at its potential as a therapeutic strategy for OS patients in need of better treatment options.
Read More
Most Useful Reviews
9
Severe anaemia recovery
1 people found this helpful
After chemotherapy, I became severely anemic. Following a month and a half in hospital, my condition improved, much to the doctors' surprise. I continue taking the medication until the end of my course, which notably does not cause constipation.
Read More
9
Successful iron treatment
1 people found this helpful
I have ordered this iron for my mother for 62 years; she has it continuously. After a year of use, her hemoglobin rose to nearly normal levels, which had been very low post-chemotherapy. The flickering she experienced before her eyes has gone, and importantly, this does not cause constipation.
Read More
9
Improved haemoglobin count
1 people found this helpful
My mother is undergoing chemotherapy, and her hemoglobin levels drop after each course. Previous pharmacy treatments didn’t work well. We decided to try this iron, and it proved effective; her hemoglobin rose from 96 g/l to 119 g/l in 20 days by taking 1 tablet in the morning on an empty stomach and having vitamin C after breakfast. All is good with her health now.
Read More
Medical Researches
SCIENTIFIC SCORE
Likely Very Effective
Based on 1 Research
9
- All Researches
9
We explored the impact of iron on chemotherapy effectiveness, particularly in the treatment of osteosarcoma (OS). The study revealed promising insights into how combining iron with eriodictyol and cisplatin could promote ferroptosis—a form of regulated cell death that can improve the overall effectiveness of cancer therapies.
The researchers discovered that eriodictyol can curb a protein known as BACH1, which leads to reduced production of GPX4, a key player in protecting cells from ferroptosis. By diminishing GPX4 levels, this combination appears to push cancer cells towards ferroptosis more effectively.
Moreover, employing hollow mesoporous nanocubes to deliver eriodictyol and cisplatin seamlessly combines these agents to enhance cell death in OS. Through multiple mechanisms, including the depletion of protective molecules and the direct initiation of fatal processes in cancer cells, the nanocomplex showed impressive results in both lab tests and animal studies.
Importantly, the treatment demonstrated effectiveness without causing significant harm to other organs, hinting at its potential as a therapeutic strategy for OS patients in need of better treatment options.
The researchers discovered that eriodictyol can curb a protein known as BACH1, which leads to reduced production of GPX4, a key player in protecting cells from ferroptosis. By diminishing GPX4 levels, this combination appears to push cancer cells towards ferroptosis more effectively.
Moreover, employing hollow mesoporous nanocubes to deliver eriodictyol and cisplatin seamlessly combines these agents to enhance cell death in OS. Through multiple mechanisms, including the depletion of protective molecules and the direct initiation of fatal processes in cancer cells, the nanocomplex showed impressive results in both lab tests and animal studies.
Importantly, the treatment demonstrated effectiveness without causing significant harm to other organs, hinting at its potential as a therapeutic strategy for OS patients in need of better treatment options.
Read More
User Reviews
USERS' SCORE
Good
Based on 6 Reviews
8.5
- All Reviews
- Positive Reviews
- Negative Reviews
9
Severe anaemia recovery
1 people found this helpful
After chemotherapy, I became severely anemic. Following a month and a half in hospital, my condition improved, much to the doctors' surprise. I continue taking the medication until the end of my course, which notably does not cause constipation.
Read More
9
Successful iron treatment
1 people found this helpful
I have ordered this iron for my mother for 62 years; she has it continuously. After a year of use, her hemoglobin rose to nearly normal levels, which had been very low post-chemotherapy. The flickering she experienced before her eyes has gone, and importantly, this does not cause constipation.
Read More
9
Improved haemoglobin count
1 people found this helpful
My mother is undergoing chemotherapy, and her hemoglobin levels drop after each course. Previous pharmacy treatments didn’t work well. We decided to try this iron, and it proved effective; her hemoglobin rose from 96 g/l to 119 g/l in 20 days by taking 1 tablet in the morning on an empty stomach and having vitamin C after breakfast. All is good with her health now.
Read More
7.5
Normalised haemoglobin
2 people found this helpful
Undergoing chemotherapy, the side effects of docetaxel caused anemia, with a decrease in platelets and white blood cells. This was concerning, so I took two tablets of docetaxel daily along with vitamin C, allowing my hemoglobin level to return to normal in three weeks. I still have more rounds of chemotherapy to complete and wish to continue taking them diligently.
Read More
8.75
Recommended during chemotherapy
This iron has been beneficial for me. I advise everyone to take it during chemotherapy; it has made a noticeable difference.
Read More
Frequently Asked Questions
9
Improved haemoglobin count
1 people found this helpful
My mother is undergoing chemotherapy, and her hemoglobin levels drop after each course. Previous pharmacy treatments didn’t work well. We decided to try this iron, and it proved effective; her hemoglobin rose from 96 g/l to 119 g/l in 20 days by taking 1 tablet in the morning on an empty stomach and having vitamin C after breakfast. All is good with her health now.
7.5
Normalised haemoglobin
2 people found this helpful
Undergoing chemotherapy, the side effects of docetaxel caused anemia, with a decrease in platelets and white blood cells. This was concerning, so I took two tablets of docetaxel daily along with vitamin C, allowing my hemoglobin level to return to normal in three weeks. I still have more rounds of chemotherapy to complete and wish to continue taking them diligently.
8.75
Recommended during chemotherapy
This iron has been beneficial for me. I advise everyone to take it during chemotherapy; it has made a noticeable difference.
9
Successful iron treatment
1 people found this helpful
I have ordered this iron for my mother for 62 years; she has it continuously. After a year of use, her hemoglobin rose to nearly normal levels, which had been very low post-chemotherapy. The flickering she experienced before her eyes has gone, and importantly, this does not cause constipation.
9
Severe anaemia recovery
1 people found this helpful
After chemotherapy, I became severely anemic. Following a month and a half in hospital, my condition improved, much to the doctors' surprise. I continue taking the medication until the end of my course, which notably does not cause constipation.
9
We explored the impact of iron on chemotherapy effectiveness, particularly in the treatment of osteosarcoma (OS). The study revealed promising insights into how combining iron with eriodictyol and cisplatin could promote ferroptosis—a form of regulated cell death that can improve the overall effectiveness of cancer therapies.
The researchers discovered that eriodictyol can curb a protein known as BACH1, which leads to reduced production of GPX4, a key player in protecting cells from ferroptosis. By diminishing GPX4 levels, this combination appears to push cancer cells towards ferroptosis more effectively.
Moreover, employing hollow mesoporous nanocubes to deliver eriodictyol and cisplatin seamlessly combines these agents to enhance cell death in OS. Through multiple mechanisms, including the depletion of protective molecules and the direct initiation of fatal processes in cancer cells, the nanocomplex showed impressive results in both lab tests and animal studies.
Importantly, the treatment demonstrated effectiveness without causing significant harm to other organs, hinting at its potential as a therapeutic strategy for OS patients in need of better treatment options.
The researchers discovered that eriodictyol can curb a protein known as BACH1, which leads to reduced production of GPX4, a key player in protecting cells from ferroptosis. By diminishing GPX4 levels, this combination appears to push cancer cells towards ferroptosis more effectively.
Moreover, employing hollow mesoporous nanocubes to deliver eriodictyol and cisplatin seamlessly combines these agents to enhance cell death in OS. Through multiple mechanisms, including the depletion of protective molecules and the direct initiation of fatal processes in cancer cells, the nanocomplex showed impressive results in both lab tests and animal studies.
Importantly, the treatment demonstrated effectiveness without causing significant harm to other organs, hinting at its potential as a therapeutic strategy for OS patients in need of better treatment options.
References
- Lin Z, Li Y, Wu Z, Liu Q, Li X, et al. Eriodictyol-cisplatin coated nanomedicine synergistically promote osteosarcoma cells ferroptosis and chemosensitivity. J Nanobiotechnology. 2025;23:109. 10.1186/s12951-025-03206-3
